Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1916 1
1927 1
1945 1
1955 1
1960 1
1961 1
1962 1
1963 1
1964 8
1965 1
1967 1
1968 1
1969 1
1971 3
1972 3
1973 2
1974 2
1975 4
1976 3
1977 4
1978 3
1979 4
1981 1
1982 1
1983 1
1985 1
1986 1
1987 3
1988 2
1989 4
1990 2
1991 4
1992 9
1994 4
1995 8
1996 6
1997 12
1998 2
1999 5
2000 13
2001 20
2002 17
2003 8
2004 18
2005 10
2006 17
2007 19
2008 19
2009 13
2010 15
2011 21
2012 20
2013 20
2014 30
2015 20
2016 26
2017 24
2018 30
2019 21
2020 19
2021 16
2022 29
2023 17
2024 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

560 results

Results by year

Filters applied: . Clear all
Page 1
Biomimetic Self-Healing.
Diesendruck CE, Sottos NR, Moore JS, White SR. Diesendruck CE, et al. Among authors: moore js. Angew Chem Int Ed Engl. 2015 Sep 1;54(36):10428-47. doi: 10.1002/anie.201500484. Epub 2015 Jul 21. Angew Chem Int Ed Engl. 2015. PMID: 26216654 Review.
Colorectal Cancer Screening.
Moore JS, Aulet TH. Moore JS, et al. Surg Clin North Am. 2017 Jun;97(3):487-502. doi: 10.1016/j.suc.2017.01.001. Surg Clin North Am. 2017. PMID: 28501242 Free article. Review.
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial.
Padrón LJ, Maurer DM, O'Hara MH, O'Reilly EM, Wolff RA, Wainberg ZA, Ko AH, Fisher G, Rahma O, Lyman JP, Cabanski CR, Yu JX, Pfeiffer SM, Spasic M, Xu J, Gherardini PF, Karakunnel J, Mick R, Alanio C, Byrne KT, Hollmann TJ, Moore JS, Jones DD, Tognetti M, Chen RO, Yang X, Salvador L, Wherry EJ, Dugan U, O'Donnell-Tormey J, Butterfield LH, Hubbard-Lucey VM, Ibrahim R, Fairchild J, Bucktrout S, LaVallee TM, Vonderheide RH. Padrón LJ, et al. Among authors: moore js. Nat Med. 2022 Jun;28(6):1167-1177. doi: 10.1038/s41591-022-01829-9. Epub 2022 Jun 3. Nat Med. 2022. PMID: 35662283 Free PMC article. Clinical Trial.
Invited Commentary.
Moore JS. Moore JS. J Am Coll Surg. 2022 Jun 1;234(6):1109-1110. doi: 10.1097/XCS.0000000000000194. Epub 2022 May 11. J Am Coll Surg. 2022. PMID: 35703806 No abstract available.
Polymers with autonomous life-cycle control.
Patrick JF, Robb MJ, Sottos NR, Moore JS, White SR. Patrick JF, et al. Among authors: moore js. Nature. 2016 Dec 14;540(7633):363-370. doi: 10.1038/nature21002. Nature. 2016. PMID: 27974778 Review.
There is Signal in Your Noise: A Case for Advanced Mass Analysis.
Suslick BA, Klok HA, Moore JS. Suslick BA, et al. Among authors: moore js. ACS Polym Au. 2022 Nov 1;2(6):392-396. doi: 10.1021/acspolymersau.2c00057. eCollection 2022 Dec 14. ACS Polym Au. 2022. PMID: 36855674 Free PMC article. No abstract available.
Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer.
Tsimberidou AM, Alayli FA, Okrah K, Drakaki A, Khalil DN, Kummar S, Khan SA, Hodi FS, Oh DY, Cabanski CR, Gautam S, Meier SL, Amouzgar M, Pfeiffer SM, Kageyama R, Yang E, Spasic M, Tetzlaff MT, Foo WC, Hollmann TJ, Li Y, Adamow M, Wong P, Moore JS, Velichko S, Chen RO, Kumar D, Bucktrout S, Ibrahim R, Dugan U, Salvador L, Hubbard-Lucey VM, O'Donnell-Tormey J, Santulli-Marotto S, Butterfield LH, Da Silva DM, Fairchild J, LaVallee TM, Padrón LJ, Sharma P. Tsimberidou AM, et al. Among authors: moore js. J Exp Med. 2024 Oct 7;221(10):e20240152. doi: 10.1084/jem.20240152. Epub 2024 Aug 27. J Exp Med. 2024. PMID: 39190534 Free PMC article.
Anisotropic Foams via Frontal Polymerization.
Alzate-Sanchez DM, Cencer MM, Rogalski M, Kersh ME, Sottos N, Moore JS. Alzate-Sanchez DM, et al. Among authors: moore js. Adv Mater. 2022 Feb;34(8):e2105821. doi: 10.1002/adma.202105821. Epub 2022 Jan 15. Adv Mater. 2022. PMID: 34762324
Coagulopathy during COVID-19 infection: a brief review.
Cunningham RM, Johnson Moore KL, Moore JS. Cunningham RM, et al. Among authors: moore js. Clin Exp Med. 2023 Jul;23(3):655-666. doi: 10.1007/s10238-022-00891-4. Epub 2022 Sep 19. Clin Exp Med. 2023. PMID: 36121504 Free PMC article. Review.
Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms.
Pétremand R, Chiffelle J, Bobisse S, Perez MAS, Schmidt J, Arnaud M, Barras D, Lozano-Rabella M, Genolet R, Sauvage C, Saugy D, Michel A, Huguenin-Bergenat AL, Capt C, Moore JS, De Vito C, Labidi-Galy SI, Kandalaft LE, Dangaj Laniti D, Bassani-Sternberg M, Oliveira G, Wu CJ, Coukos G, Zoete V, Harari A. Pétremand R, et al. Among authors: moore js. Nat Biotechnol. 2024 May 7. doi: 10.1038/s41587-024-02232-0. Online ahead of print. Nat Biotechnol. 2024. PMID: 38714897
560 results